Notably, we have shown that, by providing a continuous supply of naturally produced, bioactive cytokines directly to the local tumor microenvironment from within our hydrogel platform, we could improve the overall therapeutic index of IL2 and allow for readministration of additional doses, if needed. Here, IL2 is linked to neoplasm.